Cargando…

Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM

BACKGROUND: Lipoprotein (a) (LP (a) is an independent cardiovascular risk factor that is not widely studied in people of sub-Saharan African origin. The aim of this report is to determine the frequency of occurrence of elevated Lp (a) and possible relationship with total cholesterol (TCHOL), high de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogbera, Anthonia O, Azenabor, Alfred O
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919447/
https://www.ncbi.nlm.nih.gov/pubmed/20663222
http://dx.doi.org/10.1186/1758-5996-2-51
_version_ 1782185184726089728
author Ogbera, Anthonia O
Azenabor, Alfred O
author_facet Ogbera, Anthonia O
Azenabor, Alfred O
author_sort Ogbera, Anthonia O
collection PubMed
description BACKGROUND: Lipoprotein (a) (LP (a) is an independent cardiovascular risk factor that is not widely studied in people of sub-Saharan African origin. The aim of this report is to determine the frequency of occurrence of elevated Lp (a) and possible relationship with total cholesterol (TCHOL), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), C reactive protein (CRP) and serum uric acid (SUA). METHODS: This is a cross sectional study carried out in 200 Nigerian patients with type 2 DM and 100 sex and age matched healthy Controls aged between 32-86 years. We determined the frequency of occurrence of elevated Lp (a) levels in the study subjects and compared clinical and biochemical variables between type 2 diabetic patients and non-diabetic patients. Clinical and biochemical parameters were also compared between subjects with type 2 DM who had elevated LP (a) and normal LP (a) levels. Long term glycaemic control using glycosylated haemoglobin was determined and compared in the study subjects. Test statistics used include chi square, correlation coefficient analysis and Student's t test. RESULTS: The mean Lp(a) concentration differed significantly between type 2 diabetic patients and the Control subjects (18.7 (5.8) mg/dl vs 23 (6.8) mg/dl, 0.00001). Similarly, the prevalence of high LP (a) levels in type 2 DM patients was significantly higher than that of the Control subjects (12.5% vs 4%, p-0.019). The mean levels of the lipid profile parameters (TCHOL, LDL-C, TG, LDL/HDL) and CRP were significantly higher in DM patients than in the Control subjects. The mean LP (a) levels were comparable in both sexes and in DM subjects with and without hypertension. TG was the only parameter that differed significantly between subjects with elevated Lp (a) levels and those with normal Lp (a) levels. There was a significant positive correlation (r) between Lp(a) levels and TG, LDL-C. TCHOL, LDL/HDL and uric acid. No association was found between Lp(a) and clinical parameters such as age and anthropometric indices. CONCLUSION: We have showed that Lp (a), CRP and other CVS risk factors cluster more in patients with DM than non DM patients. Serum Lp (a) levels are not associated with anthropometric and glycaemic indices.
format Text
id pubmed-2919447
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29194472010-08-11 Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM Ogbera, Anthonia O Azenabor, Alfred O Diabetol Metab Syndr Research BACKGROUND: Lipoprotein (a) (LP (a) is an independent cardiovascular risk factor that is not widely studied in people of sub-Saharan African origin. The aim of this report is to determine the frequency of occurrence of elevated Lp (a) and possible relationship with total cholesterol (TCHOL), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), C reactive protein (CRP) and serum uric acid (SUA). METHODS: This is a cross sectional study carried out in 200 Nigerian patients with type 2 DM and 100 sex and age matched healthy Controls aged between 32-86 years. We determined the frequency of occurrence of elevated Lp (a) levels in the study subjects and compared clinical and biochemical variables between type 2 diabetic patients and non-diabetic patients. Clinical and biochemical parameters were also compared between subjects with type 2 DM who had elevated LP (a) and normal LP (a) levels. Long term glycaemic control using glycosylated haemoglobin was determined and compared in the study subjects. Test statistics used include chi square, correlation coefficient analysis and Student's t test. RESULTS: The mean Lp(a) concentration differed significantly between type 2 diabetic patients and the Control subjects (18.7 (5.8) mg/dl vs 23 (6.8) mg/dl, 0.00001). Similarly, the prevalence of high LP (a) levels in type 2 DM patients was significantly higher than that of the Control subjects (12.5% vs 4%, p-0.019). The mean levels of the lipid profile parameters (TCHOL, LDL-C, TG, LDL/HDL) and CRP were significantly higher in DM patients than in the Control subjects. The mean LP (a) levels were comparable in both sexes and in DM subjects with and without hypertension. TG was the only parameter that differed significantly between subjects with elevated Lp (a) levels and those with normal Lp (a) levels. There was a significant positive correlation (r) between Lp(a) levels and TG, LDL-C. TCHOL, LDL/HDL and uric acid. No association was found between Lp(a) and clinical parameters such as age and anthropometric indices. CONCLUSION: We have showed that Lp (a), CRP and other CVS risk factors cluster more in patients with DM than non DM patients. Serum Lp (a) levels are not associated with anthropometric and glycaemic indices. BioMed Central 2010-07-27 /pmc/articles/PMC2919447/ /pubmed/20663222 http://dx.doi.org/10.1186/1758-5996-2-51 Text en Copyright ©2010 Ogbera and Azenabor; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ogbera, Anthonia O
Azenabor, Alfred O
Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title_full Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title_fullStr Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title_full_unstemmed Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title_short Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
title_sort lipoprotein (a), c-reactive protein and some metabolic cardiovascular risk factors in type 2 dm
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919447/
https://www.ncbi.nlm.nih.gov/pubmed/20663222
http://dx.doi.org/10.1186/1758-5996-2-51
work_keys_str_mv AT ogberaanthoniao lipoproteinacreactiveproteinandsomemetaboliccardiovascularriskfactorsintype2dm
AT azenaboralfredo lipoproteinacreactiveproteinandsomemetaboliccardiovascularriskfactorsintype2dm